A Comparison of Remifentanil Parturient-Controlled Intravenous Analgesia with Epidural Analgesia
Authors:
- Xiu-Bin ChenXCXiu-Bin Chen
- Hai-Bing LiHLHai-Bing Li
- Man-Tang QiuMQMan-Tang Qiu
- Tao DuanTDTao Duan
- 1 March 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 118 (3) , 598-603
Abstract
Epidural analgesia is generally accepted as the most effective form of pain relief during labor. Remifentanil patient-controlled IV analgesia (PCIA), which is less invasive than epidural analgesia, may be an attractive alternative. In this meta-analysis, we compared the efficacy and safety of the 2 analgesic techniques for labor pain. Databases of PubMed, EMBASE, and Cochrane Library were searched independently by 2 reviewers to retrieve eligible randomized controlled clinical trials. The primary end points were pain scores at 1 and 2 hours, and the secondary end points were nausea, vomiting, pruritus, and umbilical artery pH values. Mean difference (MD) or risk ratio with 95% confidence intervals (CIs) were calculated for each end point. GRADE profiler was applied to assess the quality of evidence. Five eligible trials were retrieved and analyzed. We found that parturients with remifentanil PCIA had higher visual analog scale (10-cm scale) pain scores than those who received epidural analgesia at 1 hour (MD = 1.9 cm; 95% CI, 0.5-3.3; I = 94%) and 2 hours (MD = 3.0 cm; 95% CI, 0.7-5.2; I = 89%) after initiation of analgesia. There was no statistical difference between epidural analgesia and remifentanil PCIA in the incidence of nausea, vomiting, pruritus, or umbilical artery pH values. However, the CIs are quite wide and contain clinically significant differences. According to GRADE profiler, most end points had moderate quality except that pain scores at 1 hour were of low quality. This meta-analysis suggests that remifentanil PCIA is not superior to epidural analgesia in analgesic efficacy during labor. Given the wide CIs of the pooled results for secondary maternal and neonatal outcomes, definite conclusions cannot be drawn for those outcomes. Further studies are still warranted to validate these conclusions.Keywords
This publication has 15 references indexed in Scilit:
- Neuraxial analgesia versus intravenous remifentanil for pain relief in early labor in nulliparous womenArchives of Gynecology and Obstetrics, 2012
- Labour analgesiaEuropean Journal of Anaesthesiology, 2012
- Respiratory arrest in an obstetric patient using remifentanil patient‐controlled analgesia*Anaesthesia, 2012
- Geburtshilfliche Analgesie in deutschen KlinikenDer Anaesthesist, 2011
- A randomised comparison of intravenous remifentanil patient-controlled analgesia with epidural ropivacaine/sufentanil during labourInternational Journal of Obstetric Anesthesia, 2011
- Remifentanil in obstetricsCurrent Opinion in Anaesthesiology, 2008
- Intravenous remifentanil vs. epidural levobupivacaine with fentanyl for pain relief in early labour: a randomised, controlled, double‐blinded studyActa Anaesthesiologica Scandinavica, 2007
- Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000Current Opinion in Anaesthesiology, 2000
- The Pharmacodynamic Effect of a Remifentanil Bolus on Ventilatory ControlAnesthesiology, 2000
- Intravenous RemifentanilAnesthesiology, 1998